tirzepatide shortage fda update Is Legal in 2026? Status, Compounding Ban & Can you still compound Tirzepatide?

Plaintiffs argue that manufacturers failed to issue adequate warnings to patients and healthcare professionals regarding these risks

No genotoxicity, mutagenicity, or organ-specific toxicity was reported at the doses tested in the preclinical safety evaluation

Brand names such as Ozempic, Wegovy , Mounjaro , and Zepbound went viral, leading to skyrocketing sales and product shortages

Patients must be counseled for the potential risk for MTC with the use of Semaglutide and let them know about symptoms of thyroid tumors (e.g

In 2025, the FDA expanded options with the approval of the Wegovy pilla non-injectable version for those preferring pills